SCHEMBL28580764

SCHEMBL28580764

COC(=O)c1ccc(Cn2c(C(=O)NC3CCC(C)CC3)cc3ccc(C#N)cc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR9 P51686 2/20 0.48
▸ F10 P00742 4/20 0.44
▸ CNR1 P21554 3/20 0.44
▸ CNR2 P34972 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LMNA P02545 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ PRKAA2 P54646 3/20 0.40
▸ HPGD P15428 1/20 0.40
▸ PRKAB2 O43741 1/20 0.39
▸ PRKAG1 P54619 1/20 0.39
▸ PRKAA1 Q13131 1/20 0.39
▸ PRKAG3 Q9UGI9 1/20 0.39
▸ PRKAG2 Q9UGJ0 1/20 0.39
▸ PRKAB1 Q9Y478 1/20 0.39
▸ BRD4 O60885 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31689691 0.91 CCR9 (0.55) CCR9F10CNR1CNR2MEN1
SCHEMBL21822131 0.91 CCR9 (0.55) CCR9F10CNR1CNR2MEN1
SCHEMBL28588621 0.89 CCR9 (0.49) CCR9F10CNR1LMNAKDM4E
SCHEMBL28588625 0.89 CCR9 (0.49) CCR9F10CNR1LMNAKDM4E
SCHEMBL21822242 0.89 CCR9 (0.48) CCR9F10CNR1CNR2MEN1
SCHEMBL21822590 0.82 CCR9 (0.48) CCR9F10CNR1KMT2ALMNA
SCHEMBL28573651 0.81 CCR9 (0.54) CCR9F10CNR1KMT2APRKAA2
SCHEMBL28573653 0.81 CCR9 (0.54) CCR9F10CNR1KMT2APRKAA2
SCHEMBL31689641 0.81 CCR9 (0.54) CCR9F10CNR1KMT2APRKAA2
SCHEMBL28573701 0.81 CNR1 (0.45) CCR9F10CNR1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112996529-A Matriptase 2 inhibitor and application thereof 迪斯克医药公司 2021-06-18 — — CN disclosed
Send feedback